| Ytd | -38.65% | |
| 1y | -49.25% |
| Open | 19.42 | Prev Close | 19.47 | Low | 18.99 | High | 19.51 | Mkt Cap | 1.11B |
| Vol | 1.49M | Avg Vol | 1.50M | EPS | -1.95 | P/E | N/A | Forward P/E | -16.74 |
| Beta | 0.90 | Short Ratio | 4.79 | Inst. Own | 100.38% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-04 | 50-d Avg | 20.13 | 200-d Avg | 25.62 | 1yr Est | 21.64 |
SAN FRANCISCO, Sept. 19, 2026 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors i
NEW YORK, Sept. 18, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former
New York, New York--(Newsfile Corp. - September 18, 2026) - Kaplan Fox & Kilsheimer LLP announces th
San Francisco, California--(Newsfile Corp. - September 18, 2026) - Hagens Berman Sobol Shapiro LLP a
TUESDAY PRCT INVESTOR DEADLINE: PROCEPT BioRobotics Corporation Investors with Substantial Losses Ha
SAN DIEGO, Sept. 18, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchaser
If you purchased or acquired Procept common stock between February 28, 2024 and February 25, 2026 an
NEW YORK, Sept. 18, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class act
New York, New York--(Newsfile Corp. - September 17, 2026) - Kaplan Fox & Kilsheimer LLP announces th
NEW ORLEANS, Sept. 17, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service,
Hagens Berman reminds investors in PROCEPT (NASDAQ: PRCT) of the September 22, 2026 lead plaintiff d
SAN FRANCISCO--(BUSINESS WIRE)---- $PRCT #PRCT--Hagens Berman is investigating claims in a class act
Time-Sensitive: Allegations focus on Procept's assurances about the handpiece-to-procedure different
LOS ANGELES, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national sha
NEW YORK, Sept. 17, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has bee
NEW YORK, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has
SAN FRANCISCO, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors i
New York, New York--(Newsfile Corp. - September 16, 2026) - Kaplan Fox & Kilsheimer LLP announces th
Executive Accountability: Hisham Shiblaq is named as a secondary defendant in allegations that PROCE
NEW YORK, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class acti
NEW YORK and NEW ORLEANS, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF
NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,
NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered L
SAN DIEGO, Sept. 15, 2026 /PRNewswire/ -- The Shareholders Foundation, Inc. announced that a lawsuit
New York, New York--(Newsfile Corp. - September 15, 2026) - Kaplan Fox & Kilsheimer LLP announces th
Shareholders who acquired PRCT shares during the October 2024 registered public offering are urged t
LOS ANGELES, Sept. 15, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises PROCEPT BioRobotics Cor
NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor
SAN FRANCISCO, Sept. 15, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in PR
BENSALEM TOWNSHIP, Pa., Sept. 14, 2026 /PRNewswire/ -- The Law Offices of Howard G.
SAN FRANCISCO, Sept. 14, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in PR
New York, New York--(Newsfile Corp. - September 14, 2026) - Kaplan Fox & Kilsheimer LLP announces th
Key dates and disclosure events shareholders need to know: the complaint alleges PROCEPT BioRobotics
LOS ANGELES, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national sha
NEW YORK, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class acti
TD Cowen analyst Joshua Jennings maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy and lower
Piper Sandler analyst Matt O'Brien maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Overwei
Evercore ISI Group analyst Vijay Kumar maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Outperf
William Blair analyst Brandon Vazquez downgrades PROCEPT BioRobotics (NASDAQ:PRCT) from Outperfor
PROCEPT BioRobotics (NASDAQ:PRCT) affirms FY2026 sales outlook from $390.000 million-$410.000 millio
PROCEPT BioRobotics (NASDAQ:PRCT) reported quarterly losses of $(0.47) per share which missed the an
Truist Securities analyst Richard Newitter downgrades PROCEPT BioRobotics (NASDAQ:PRCT) from Buy
Wall Street analysts upgraded various top stocks, including Nucor, Varonis, Invitation Homes, and Ma
Wall Street analysts changed outlook on top names, see all changes on Benzinga's analyst ratings
Evercore ISI Group analyst Vijay Kumar initiates coverage on PROCEPT BioRobotics (NASDAQ:PRCT) wi
Health care sector's oversold stocks present buying opportunity; RSI below 30 signals oversold,
Wall Street analysts changed outlook on top names like MKTX, PRCT, VOD, and JILL. See ratings page a
Leerink Partners analyst Mike Kratky downgrades PROCEPT BioRobotics (NASDAQ:PRCT) from Outperform